To add to this, if it was not immediately obvious, it's now possible that we have at least 4 clinical trials up and running by the end of the year:
Israel AML
Extramedullary AML Stratum 1 and Stratum 2
Breast cancer + cardio-protection
ccRCC + TKI combination
That's based on what we know now, so there's a possibility that there are still things that might be added to this list. If not starting this year then soon after.
I assume that all of these trials would all be open label with continuous readouts (as Daniel has confirmed for at least some of them), so we can expect real ongoing news flow to increase in frequency accordingly.
RAC Price at posting:
$2.81 Sentiment: Buy Disclosure: Held
(20min delay)